N-Desmethyl-6-O-methylerythromycin (9E)-Oxime
CAS: 127182-43-8
Ref. TR-D292310
| 5mg | 345.00 € | ||
| 50mg | 2,320.00 € |
Estimated delivery in United States, on Tuesday 15 Oct 2024
Product Information
Name:
N-Desmethyl-6-O-methylerythromycin (9E)-Oxime
Controlled Product
Synonyms:
- 3''-N-Demethyl-6-O-methylerythromycin A (E)-9-oxime
- Oxacyclotetradecane
- erythromycin deriv.
- Clarithromycin Imp. M (EP)
Description:
Applications N-Desmethyl-6-O-methylerythromycin (9E)-Oxime is a derivative of Clarithromycin (C559750); a semi-synthetic macrolide antibiotic and derivative of Erythromycin (E650000).
References Benson, C., et al.: Eur. J. Clin. Microbiol., 6, 173 (1987); Boyanova, L., et al.: J. Med. Microb., 61, 85 (2012); Lin, Z., et al.: Toxicol. Sci., 126, 114 (2012)
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
748.94
Formula:
C37H68N2O13
Color/Form:
Neat
InChI:
InChI=1S/C37H68N2O13/c1-14-25-37(10,44)30(41)20(4)27(39-45)18(2)16-36(9,47-13)32(52-34-28(40)24(38-11)15-19(3)48-34)21(5)29(22(6)33(43)50-25)51-26-17-35(8,46-12)31(42)23(7)49-26/h18-26,28-32,34,38,40-42,44-45H,14-17H2,1-13H3/b39-27+/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
InChI key:
InChIKey=MPBKKWQXSHKTAP-UXZNNQEFSA-N
SMILES:
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](NC)[C@H]2O)[C@](C)(OC)C[C@@H](C)/C(=N\O)[C@H](C)[C@@H](O)[C@]1(C)O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-D292310 N-Desmethyl-6-O-methylerythromycin (9E)-Oxime
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
